Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells.
about
Selection of P-Glycoprotein Inhibitor and Formulation of Combinational Nanoformulation Containing Selected Agent Curcumin and DOX for Reversal of Resistance in K562 Cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Selection of P-Glycoprotein In ...... l of Resistance in K562 Cells.
@en
Selection of P-Glycoprotein In ...... l of Resistance in K562 Cells.
@nl
type
label
Selection of P-Glycoprotein In ...... l of Resistance in K562 Cells.
@en
Selection of P-Glycoprotein In ...... l of Resistance in K562 Cells.
@nl
prefLabel
Selection of P-Glycoprotein In ...... l of Resistance in K562 Cells.
@en
Selection of P-Glycoprotein In ...... l of Resistance in K562 Cells.
@nl
P2860
P1476
Selection of P-Glycoprotein In ...... al of Resistance in K562 Cells
@en
P2093
V Badireenath Konkimalla
P2860
P304
P356
10.1007/S11095-017-2182-7
P577
2017-05-23T00:00:00Z